|
000
| 02508nam 2200385zi 4500 |
|---|
| 001 | 9.894145 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20221107173643 |
|---|
| 006 | m o d f |
|---|
| 007 | cr cn||||||||| |
|---|
| 008 | 201130e20180702onc ob f000 0 eng d |
|---|
| 040 | |aCaOODSP|beng|erda|cCaOODSP |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aHP45-22/2018E-PDF |
|---|
| 245 | 00|aCanadian biosafety guideline : |bdual-use in life science research. |
|---|
| 246 | 17|aDraft guideline – dual-use in life science research |
|---|
| 250 | |aDraft. |
|---|
| 264 | 1|aOttawa : |bPublic Health Agency of Canada, |cJuly 2, 2018. |
|---|
| 264 | 4|c©2018 |
|---|
| 300 | |a1 online resource (x, 29 pages, 8 unnumbered pages) |
|---|
| 336 | |atext|btxt|2rdacontent |
|---|
| 337 | |acomputer|bc|2rdamedia |
|---|
| 338 | |aonline resource|bcr|2rdacarrier |
|---|
| 500 | |aAlso issued in French under title: Ligne directrice canadienne sur la biosécurité : le double usage dans la recherche ensciences de la vie. |
|---|
| 500 | |aIssued also in HTML format. |
|---|
| 504 | |aIncludes bibliographical references. |
|---|
| 520 | 2 |a"Dual-Use in Life Science Research was developed by the PHAC and the CFIA as part of a series of electronic publications that expand upon the biosafety and biosecurity concepts discussed in the current edition of the Canadian Biosafety Handbook (CBH), the companion document to the Canadian Biosafety Standard (CBS). This guideline provides guidance on how to identify and mitigate dual-use potential in research involving pathogens, toxins, or other infectious material. In addition, the governance of research with dual-use potential in Canada and other international jurisdictions is discussed. This guideline is intended to assist regulated parties in meeting the requirements specified in the CBS, but should not be interpreted as requirements. Regulated parties may choose alternate approaches to meet the requirements specified in the CBS"--Page vii. |
|---|
| 650 | 0|aBiosecurity|zCanada. |
|---|
| 650 | 0|aBiological laboratories|zCanada|xSafety measures. |
|---|
| 650 | 0|aHazardous substances|xRisk assessment|zCanada. |
|---|
| 710 | 2 |aPublic Health Agency of Canada, |eissuing body. |
|---|
| 775 | 08|tLigne directrice canadienne sur labiosécurité : |w(CaOODSP)9.894149 |
|---|
| 856 | 40|qPDF|s1.02 MB|uhttps://publications.gc.ca/collections/collection_2020/aspc-phac/HP45-22-2018-eng.pdf |
|---|
| 856 | 4 |qHTML|sN/A|uhttps://www.canada.ca/en/public-health/programs/consultation-biosafety-guideline-dual-use-life-science-research/document.html |
|---|